| 货号:SYN-1081-M001 | 规格:1 mg | 目录价:¥1204 |
| 货号:SYN-1081-M005 | 规格:5 mg | 目录价:¥1960 |
| 货号:SYN-1081-M010 | 规格:10 mg | 目录价:¥3024 |
| 货号:SYN-1081-M050 | 规格:50 mg | 目录价:¥9828 |
| 货号:SYN-1081-M100 | 规格:100 mg | 目录价:¥询价 |
产品详情
* 以下信息仅供参考,详情请以原厂网站为准
产品名称:
SNS-314
别名:
SNS314
产品描述:
Aurora kinases constitute a family of serine-threonine kinases that are strongly associated with cancer. Aurora A and B are essential in mitosis. Perturbation of their activity leads to multiple defects in mitosis including aberrant centrosome duplication, misalignment of chromosomes, inhibition of cytokinesis, and disruption of the spindle checkpoint. The role of Aurora C is unclear; however, Aurora C can complement Aurora B kinase activity in mitosis. SNS-314 is an ATP-competitive, selective, and potent nanomolar inhibitor of aurora kinases in vitro. A cocrystal structure of SNS-314 with Aurora A confirms that SNS-314 engages the purine-binding pocket of Aurora. SNS-314 inhibits cellular proliferation in the HCT116 colorectal carcinoma cell line with an EC50 of ~5nM. Analysis of DNA content and indirect immunofluoresence demonstrates that SNS-314 induces defects in cytokinesis and spindle checkpoint that are consistent with Aurora kinase inhibition. Phosphorylation of Histone H3 on serine 10, a known Aurora B cellular target, is inhibited with an EC50 of ~9nM following treatment of cells with SNS-314. Administration of SNS-314 to HCT116 tumor bearing mice potently suppresses tumor growth. Analysis of SNS-314 treated tumors confirms that the anti-tumor activity is consistent with Aurora kinase inhibition. SNS-314 is a potent small-molecule inhibitor of Aurora kinase that is being developed as a novel anti-cancer therapeutic agent.
保存温度:
+4°C
运输温度:
Ambient
预期分子量:
430.9
产品形式:
solid
产地:
瑞士
纯度:
>95%
CAS号:
1057249-41-8
分子式:
C18H15ClN6OS2
您可能感兴趣的产品
促销活动
精品推荐

官网链接
折扣/货期




复制QQ号成功,请打开QQ后添加好友进行咨询